Procaps Group: production expansion in US
Procaps Group has announced its acquisition of a 86,000-square-foot production facility in West Palm Beach Florida, its first manufacturing reach into the US. The facility (purchased from Strides Pharma) reportedly offers a annual production capacity of about 1.8b capsules, expanding the company’s product development capabilities by more than 70%.
“This acquisition is an important milestone for our strategy of bringing soft gelatin-based innovations to all corners of the globe both via integrated CDMO solutions and our own developments,” said Ruben Minski, CEO of Procaps Group. “This facility has a strong production track record and audit history and we believe it will become a global center of pharmaceutical excellence.”